Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Cytarabine Benvenue 1g*


Contraindicated
Teratogenic in animals

Contraindicated
Cytarabine Benvenue 1g* :
Type Medicine Non Marketed
Originator Cytosar 1g
Agent Pharmamed
Distributor Pharmamed
Laboratory Benvenue Laboratories
Responsible Party Benvenue Laboratories
Origin U.S.A.
Manufacturer Benvenue Laboratories Inc
Manufacturing Type G
Origin U.S.A.
ATC L01BC01

Your comment will appear shortly after approval

Cytarabine Benvenue 1g* :

Revision Date : 18/05/2011


Effect Frequency
Arachnoiditis Very Common
Asthenia Very Common
Back pain Common
Blindness Common
Cauda equina syndrome Not known
Confusional state Common
Cranial nerve paralysis Common
CSF protein increased Not known
Deafness Common
Diarrhoea (Diarrhea) Very Common
Faecal incontinence Common
Fatigue Common
Headache Very Common
Hemiplegia Common
Hydrocephalus Common
Hypoesthesia Common
Incontinence Not known
Meningitis Uncommon
Musculoskeletal stiffness Common
Myelopathy Common
Nausea Very Common
Neck pain Not known
Neuropathy peripheral Not known
Pain Common
Paraesthesia (paresthesia) Common
Pleocytosis Common
Pyrexia Very Common
Seizures Common
Somnolence Common
Thrombocytopenia (Thrombopenia) Very Common
Urinary incontinence Common
Visual disturbance Common
Vomiting Very Common
White blood cell count increased Not known

Different Units By MoH Code

Revision Date : 01/08/2000

Cytarabine Benvenue 1g*  MoH 962 :
Form Solution for injection
Packaging Bottle
Package Size 1x20ml
Strength 1g
NSSF ✘
Quarantine ✘
Reg. Number 208257/97
Submission date 01/01/1997
Registration Year 1997
Archived Date 2014


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info